Pubblicazioni

PANITUMUMAB IN COMBINATION WITH INFUSIONAL OXALIPLATIN AND ORAL CAPECITABINE FOR CONVERSION THERAPY IN PATIENTS WITH COLON CANCER AND ADVANCED LIVER METASTASES

PANITUMUMAB IN COMBINATION WITH INFUSIONAL OXALIPLATIN AND ORAL CAPECITABINE FOR CONVERSION THERAPY IN PATIENTS WITH COLON CANCER AND ADVANCED LIVER METASTASES. The MetaPan Study. Francesco Leone; Salvatore Artale; Donatella Marino; Celeste Cagnazzo; Stefano Cascinu; Carmine Pinto; Giuseppe Fornarini; Marco Tampellini; Francesca Di Fabio; Andrea Sartore-Bianchi; Luciano De Carlis; Raffaele Pugliese; Lorenzo Capussotti; Luisa Gioeni; Salvatore Siena; and Massimo Aglietta.

Allegati